We are live on ! Find out more
83.18 USD
+3.46
4.34%
At close Updated Nov 2, 4:00 PM EST
Pre-market
After hours
82.72
-0.46
0.55%
1 day
4.34%
5 days
3.21%
1 month
19.36%
3 months
7.89%
6 months
-26.18%
Year to date
-33.94%
1 year
-42.38%
5 years
-60.8%
10 years
65.99%
 

About: Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Employees: 14,500

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 35.4%
Neutral 47.9%
Negative 16.7%
Neutral
Zacks Investment Research
4 days ago
Zoetis (ZTS) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Zoetis (ZTS) closed at $78.8, indicating a +1.29% shift from the previous trading day.
Zoetis (ZTS) Ascends While Market Falls: Some Facts to Note
Positive
Zacks Investment Research
4 days ago
Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Positive
Zacks Investment Research
5 days ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Neutral
Zacks Investment Research
10 days ago
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Zoetis (ZTS) closed at $81.03, marking a -1.18% move from the previous day.
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
Positive
Zacks Investment Research
12 days ago
ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?
Zoetis offers diversification and stability, while ImmuCell boasts stronger sales growth and expansion potential.
ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?
Neutral
Business Wire
13 days ago
Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Convenia RTU for Dogs provides up to 14 days of antibiotic treatment in a single dose for susceptible bacterial skin infections.
Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment
Neutral
Business Wire
20 days ago
Zoetis Appoints Iris Knobloch to its Board of Directors
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Iris Knobloch to its Board of Directors, effective as of December 1, 2026. With decades of experience across global media and consumer businesses, Ms. Knobloch brings a distinct combination of international leadership, proven public company board experience across financial services, hospitality and media, and deep consumer and digital expertise to the Zoetis Board. She currently serves on the boards of.
Zoetis Appoints Iris Knobloch to its Board of Directors
Neutral
Seeking Alpha
22 days ago
10 Dividend Growth Stocks: October 2026
In this monthly series, I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. This month's screen targets dividend growth stocks with Dividend Safety scores ≥8.0, forward yields ≥2.5%, and prices at or below fair value. An equally weighted portfolio of the top 10 stocks yields 2.8% but would have underperformed SPY over the past 5 years.
10 Dividend Growth Stocks: October 2026
Positive
Seeking Alpha
22 days ago
Top 50 High-Quality Dividend Growth Stocks For October 2026
I track an investable universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and future return potential. Applied Materials, D.R. Horton, and Home Depot saw notable ranking improvements due to upgraded EPS growth estimates and/or favorable valuation shifts. 44 out of 50 stocks currently offer a forward return estimate of at least 10%, with 32 appearing potentially undervalued based on free cash flow mean reversion.
Top 50 High-Quality Dividend Growth Stocks For October 2026
Positive
Zacks Investment Research
24 days ago
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
In the most recent trading session, Zoetis (ZTS) closed at $74.81, indicating a +2.37% shift from the previous trading day.
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
Price charts implemented using Lightweight Charts™